Should you buy PYXS stock?
Last updated:
Based on market data through , StockInvest.us rates Pyxis Oncology, Inc. (PYXS) as a Strong Buy Candidate with a technical score of 5.85 on its -10 to +10 scale. This is an upgrade from Buy in the previous daily evaluation.
- Buy signal since
- Price since signal Up 88.67%
- 3-month trend forecast Up 47.86%
- +268.3% price growth over the last year
- High gross margin of 99.8%
- +233.0% YTD performance
Stronger technical forecast for Pyxis Oncology, Inc. stock price after Monday trading
(Market data through Aug 10, 2026)
The Pyxis Oncology, Inc. stock price gained 2.68% on the last trading day (Monday, 10th Aug 2026), rising from $3.73 to $3.83. During the last trading day the stock fluctuated 7.12% from a day low at $3.72 to a day high of $3.99. The price has risen in 5 of the last 10 days and is up by 31.62% over the past 2 weeks. Volume fell on the last day by -222 thousand shares and in total, 997 thousand shares were bought and sold for approximately $3.82 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $4.07 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 47.86% during the next 3 months and, with a 90% probability hold a price between $4.04 and $6.01 at the end of this 3-month period.
PYXS Signals & Forecast
Mostly positive signals in the chart today. The Pyxis Oncology, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.33 and $2.72. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 26, 2026, and so far it has risen 134.97%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Pyxis Oncology, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $3.07 and $3.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pyxis Oncology, Inc. finds support just below today's level at $3.07. If this is broken, then the next support from accumulated volume will be at $3.01 and $2.91.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.265 between high and low, or 7.12%. For the last week, the stock has had daily average volatility of 10.18%.
The Pyxis Oncology, Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stop-loss: $3.72 (-2.82%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 84 and this increases the risk substantially. There is a buy signal from a pivot bottom found 52 days ago.)
Trading Expectations (PYXS) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Pyxis Oncology, Inc. to open at $3.85, and during the day (based on 14 day Average True Range), to move between $3.68 and $3.98, which gives a possible trading interval of +/-$0.297 (+/-8.07%) up or down from last closing price. If Pyxis Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 8.07% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $3.07, some $0.760 (19.84%) from the current price of $3.83, our system finds the risk reward attractive.
Earnings coming up
Pyxis Oncology, Inc. will release earnings BMO on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.350. We will update the financials statements for Pyxis Oncology, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 13.16% in the first trading day after earnings release.
Is Pyxis Oncology, Inc. stock A Buy?
Pyxis Oncology, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
5.849
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $3.85 ( 0.392%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PYXS Performance
Trading levels for PYXS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.11 | 7.31% |
| R2 | 4.01 | 4.67% |
| R1 | 3.95 | 3.03% |
| Price | 3.83 | |
| S1 | 3.74 | -2.25% |
| S2 | 3.68 | -3.88% |
| S3 | 3.58 | -6.53% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 3.83 | |
| S1 | 3.07 | -19.84% |
| S2 | 3.01 | -21.41% |
| S3 | 2.91 | -24.02% |
FAQ
Click here for our free guide on how to buy Pyxis Oncology, Inc. Stock.
Buy PYXS